Connexin-26 Is a Key Factor Mediating Gemcitabine Bystander Effect
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-10-0693
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2011
Authors
Publisher
American Association for Cancer Research (AACR)